Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.This is an entirely free service. No payments are to be made.
Here is the latest stock price and chart of Orchid Chemicals. For more details, see the Orchid Chemicals company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
|Live BSE Quotes||Jan 19, 2017 (Close)|
|Price (Rs)28.65||Open (Rs) 28.60||High (Rs) 28.95||Low (Rs) 28.55|
|% Change0.35||Volume 56,141||Value (Rs) 1,613,006||52-Week H/L 47.60 / 23.70|
|Live NSE Quotes||Jan 19, 2017 3:24:58 PM|
|Price (Rs)28.65||Open (Rs) 28.60||High (Rs) 28.95||Low (Rs) 28.45|
|% Change0.35||Volume 149,781||Value (Rs) 4,289,728||52-Week H/L 75.55 / 42.50|
|EPS (Rs)* -35.93||P/E Ratio (x) NM||Market Cap (Rs m) 2,442.70||P/BV (x) 0.64|
|*Trailing 12 months earnings, excluding extraordinary / exceptional items.||BSE Sensex | CNX Nifty|
|ORCHID PHARMA LTD Stock Price Chart (Rs) - 1 Year|
Quote & Graph
S&P BSE SENSEX
The Indian share markets finished the day on flat note amid mixed Asian cues. At the closing bell, the BSE Sensex closed higher by 51 points, whereas the NSE Nifty finished higher by 18 points.
Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.
Glenmark has announced its 2QFY16 results. The company has reported 15.7% YoY growth in net sales and 3.5% YoY increase in net profits. Here is our analysis of the results.
Biocon has announced its 2QFY17. The company has reported 19.8% YoY growth in net sales and profits of Rs 1.5 bn for the quarter. Here is our analysis of the results.
Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.
Cipla has announced its results for the June quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.More Views on News